Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
Illuminating Patient Selection for PBM in AMD: A Case-Based Discussion
October 10, 2026 New Orleans, Louisiana
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Michael A. Klufas, MD
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Diagnostic Vitrectomy for Infectious Uveitis
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Uncovering the Drivers of Dry Eye Symptoms
Steve Jackson, PharmD
Anat Galor, MD, MSPH
Rethinking Dry Eye Disease: Evolving Strategies for Evaluation and Care
Esen K. Akpek, MD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Why QoL Measures Change TED Management
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Andrea Lora Kossler, MD, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Why Staging TED Correctly Matters Even When CAS Is Low
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.